Page last updated: 2024-08-21

pyrazines and Rhabdomyolysis

pyrazines has been researched along with Rhabdomyolysis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biava, G; Brucato, A; Ippolito, G; Nicastri, E; Petrosillo, N; Uyeki, TM1
Kao, DP; Kohrt, HE; Kugler, J1
Boucher, BJ1
DiGregorio, RV; Pasikhova, Y1
Bhome, R; Penn, H1
Hildebrandt, GC; Panu, LD; Shahan, JL1
Arenillas, L; Bladé, J; Cibeira, MT; Mercadal, S; Muntañola, A; Salamero, O1

Other Studies

7 other study(ies) available for pyrazines and Rhabdomyolysis

ArticleYear
Acute rhabdomyolysis and delayed pericardial effusion in an Italian patient with Ebola virus disease: a case report.
    BMC infectious diseases, 2017, 08-30, Volume: 17, Issue:1

    Topics: Adrenal Cortex Hormones; Adult; Amides; Antibodies, Monoclonal; Ebolavirus; Health Personnel; Hemorrhagic Fever, Ebola; Humans; Indomethacin; Italy; Male; Pericardial Effusion; Pyrazines; Rhabdomyolysis; Sierra Leone

2017
Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use.
    Diabetic medicine : a journal of the British Diabetic Association, 2008, Volume: 25, Issue:10

    Topics: Acute Kidney Injury; Aged; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrazines; Rhabdomyolysis; Simvastatin; Sitagliptin Phosphate; Triazoles

2008
Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use. But what about the amiodarone?
    Diabetic medicine : a journal of the British Diabetic Association, 2009, Volume: 26, Issue:2

    Topics: Amiodarone; Contraindications; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Liver-Specific Organic Anion Transporter 1; Male; Organic Anion Transporters; Pyrazines; Renal Insufficiency; Rhabdomyolysis; Simvastatin; Sitagliptin Phosphate; Triazoles; United Kingdom; United States

2009
Rhabdomyolysis caused by a potential sitagliptin-lovastatin interaction.
    Pharmacotherapy, 2009, Volume: 29, Issue:3

    Topics: Aged; Anticholesteremic Agents; Drug Interactions; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Lovastatin; Pyrazines; Rhabdomyolysis; Sitagliptin Phosphate; Triazoles

2009
Rhabdomyolysis precipitated by a sitagliptin-atorvastatin drug interaction.
    Diabetic medicine : a journal of the British Diabetic Association, 2012, Volume: 29, Issue:5

    Topics: Aged; Atorvastatin; Drug Interactions; Drug Therapy, Combination; Heptanoic Acids; Humans; Male; Pyrazines; Pyrroles; Rhabdomyolysis; Sitagliptin Phosphate; Treatment Outcome; Triazoles

2012
Rhabdomyolysis in a multiple myeloma patient secondary to concurrent treatment with lenalidomide and pravastatin and to lenalidomide alone.
    International journal of hematology, 2012, Volume: 96, Issue:6

    Topics: Amines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Boronic Acids; Bortezomib; Combined Modality Therapy; Creatine Kinase, MM Form; Cyclohexanecarboxylic Acids; Dexamethasone; Drug Synergism; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Immunologic Factors; Kidney Diseases; Lenalidomide; Melphalan; Middle Aged; Multiple Myeloma; Peripheral Blood Stem Cell Transplantation; Polyneuropathies; Pravastatin; Pyrazines; Rhabdomyolysis; Thalidomide

2012
Bortezomib-induced rhabdomyolysis in multiple myeloma.
    Acta haematologica, 2006, Volume: 116, Issue:3

    Topics: Boronic Acids; Bortezomib; Humans; Male; Middle Aged; Multiple Myeloma; Pyrazines; Recurrence; Rhabdomyolysis; Salvage Therapy

2006